Endocrinological Study of the Dopaminergic Regulation of Prolactin Release in Metastatic Breast Cancer
暂无分享,去创建一个
S. Barni | M. Mandalà | A. Ardizzoia | P. Lissoni | C. Moro | F. Rovelli | G. Fumagalli | L. Giani | G. Confalonieri | Gabriele Tancini | Fabio Malugani
[1] Charles B. Wilson,et al. The Case for Initial Surgical Removal of Certain Prolactinomas , 1997 .
[2] D. Johnson,et al. The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells. , 1995, Anti-cancer drugs.
[3] J. Tomaszewski,et al. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. , 1995, The American journal of pathology.
[4] B. Jankovič,et al. Neuroimmunomodulation From Phenomenology to Molecular Evidence a , b , 1994 .
[5] D. Giri,et al. Plasma prolactin as an indicator of disease progression in advanced breast cancer , 1990, Cancer.
[6] J. Bonneterre,et al. Prolactin receptors (PRL-R) and breast cancer. , 1989, European journal of cancer & clinical oncology.
[7] V. Vinnitsky. Neurohumoral Mechanisms of the Formation of Antitumoral Activity , 1988, Annals of the New York Academy of Sciences.
[8] S. Barni,et al. Prolactin Response to Thyrotropin-Releasing Hormone in Early and Advanced Human Breast Cancer , 1986, Tumori.
[9] H. Rauschecker,et al. Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer , 1984, International journal of cancer.
[10] H. Nagasawa,et al. Prolactin and murine mammary tumorigenesis: a review. , 1977, Cancer research.
[11] Ward Hw. Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma. , 1977 .
[12] H. Ward. Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma. , 1977, Clinics in oncology.
[13] A. Barrett,et al. Bromocriptine in the treatment of advanced breast cancer. , 1976, Clinical oncology.